Microsoft outlined steps for developers to migrate existing C++ projects to Visual Studio 2026 with updated toolsets, standards, and SDKs.
Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback